247 related articles for article (PubMed ID: 25642761)
21. Hematopoietic stem cell transplantation activity in Europe 1999.
Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
[TBL] [Abstract][Full Text] [Related]
22. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
[TBL] [Abstract][Full Text] [Related]
23. Hematopoietic precursor cell transplants in Europe: activity in 1994. Report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J; Baldomero H
Bone Marrow Transplant; 1996 Feb; 17(2):137-48. PubMed ID: 8640158
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: current options and future potential.
Hwang WY; Ong SY
Ann Acad Med Singap; 2009 Apr; 38(4):340-6. PubMed ID: 19434337
[TBL] [Abstract][Full Text] [Related]
25. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
26. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.
Passweg JR; Baldomero H; Chabannon C; Basak GW; de la Cámara R; Corbacioglu S; Dolstra H; Duarte R; Glass B; Greco R; Lankester AC; Mohty M; Peffault de Latour R; Snowden JA; Yakoub-Agha I; Kröger N;
Bone Marrow Transplant; 2021 Jul; 56(7):1651-1664. PubMed ID: 33623153
[TBL] [Abstract][Full Text] [Related]
27. The EBMT activity survey 2008: impact of team size, team density and new trends.
Gratwohl A; Baldomero H; Schwendener A; Gratwohl M; Apperley J; Frauendorfer K; Niederwieser D
Bone Marrow Transplant; 2011 Feb; 46(2):174-91. PubMed ID: 20348970
[TBL] [Abstract][Full Text] [Related]
28. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors.
Gratwohl A; Baldomero H; Frauendorfer K; Urbano-Ispizua A; Niederwieser D; ;
Bone Marrow Transplant; 2007 Jan; 39(2):71-87. PubMed ID: 17213849
[TBL] [Abstract][Full Text] [Related]
29. European survey on clinical use of cord blood for hematopoietic and non-hematopoietic indications.
Gratwohl A; Baldomero H
Transfus Apher Sci; 2010 Jun; 42(3):265-75. PubMed ID: 20427240
[TBL] [Abstract][Full Text] [Related]
30. The EBMT activity survey 2009: trends over the past 5 years.
Baldomero H; Gratwohl M; Gratwohl A; Tichelli A; Niederwieser D; Madrigal A; Frauendorfer K;
Bone Marrow Transplant; 2011 Apr; 46(4):485-501. PubMed ID: 21358689
[TBL] [Abstract][Full Text] [Related]
31. Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report.
Passweg JR; Baldomero H; Bader P; Basak GW; Bonini C; Duarte R; Dufour C; Kröger N; Kuball J; Lankester A; Montoto S; Nagler A; Snowden JA; Styczynski J; Mohty M;
Bone Marrow Transplant; 2018 Sep; 53(9):1139-1148. PubMed ID: 29540849
[TBL] [Abstract][Full Text] [Related]
32. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Hermans J
Clin Transplant; 1995 Oct; 9(5):355-63. PubMed ID: 8541627
[TBL] [Abstract][Full Text] [Related]
33. Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
Konuma T; Kanda J; Uchida N; Nishijima A; Tanaka M; Ozawa Y; Sawa M; Onizuka M; Ota S; Maruyama Y; Kanda Y; Kawakita T; Ara T; Eto T; Nakamae H; Kimura T; Fukuda T; Atsuta Y;
Hematol Oncol; 2023 Feb; 41(1):147-158. PubMed ID: 36268564
[TBL] [Abstract][Full Text] [Related]
34. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
Kindwall-Keller TL; Ballen KK
Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic stem cell transplantation in Europe 1998.
Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.
Fitzhugh CD; Abraham AA; Tisdale JF; Hsieh MM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1171-85. PubMed ID: 25459186
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Graft Acquisition and Early Direct Charges of Haploidentical Related Donor Transplantation versus Umbilical Cord Blood Transplantation.
Kanate AS; Szabo A; Raj RV; Bower K; Grulke R; Shah N; Ross KG; Cumpston A; Craig M; Pasquini MC; Shah N; Hari P; Hamadani M; Chhabra S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1456-1464. PubMed ID: 30878605
[TBL] [Abstract][Full Text] [Related]
38. Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.
Srinivasan A; Raffa E; Wall DA; Schechter T; Ali M; Chopra Y; Kung R; Chiang KY; Krueger J
Transplant Cell Ther; 2022 Mar; 28(3):158.e1-158.e9. PubMed ID: 34838785
[TBL] [Abstract][Full Text] [Related]
39. Alternative donor transplant of benign primary hematologic disorders.
Tolar J; Sodani P; Symons H
Bone Marrow Transplant; 2015 May; 50(5):619-27. PubMed ID: 25665040
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status.
Konuma T; Yamasaki S; Ishiyama K; Mizuno S; Hayashi H; Uchida N; Shimabukuro M; Tanaka M; Kuriyama T; Onizuka M; Ishiwata K; Sawa M; Tanaka T; Ohigashi H; Fujiwara SI; Matsuoka KI; Ota S; Nishida T; Kanda Y; Fukuda T; Atsuta Y; Nakasone H; Yanada M;
Transplant Cell Ther; 2024 Feb; 30(2):215.e1-215.e18. PubMed ID: 38081415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
